Vir Biotechnology, Inc. (VIR)
NASDAQ: VIR · Real-Time Price · USD
10.47
+0.06 (0.58%)
At close: Oct 15, 2026, 4:00 PM EDT
10.50
+0.03 (0.29%)
After-hours: Oct 15, 2026, 7:57 PM EDT
Vir Biotechnology Market Cap
Vir Biotechnology has a market cap or net worth of $1.77 billion as of October 15, 2026. It is the 7,188th most valuable company in the world and the 1,853rd biggest in the United States. Its market cap has increased by 122.97% in one year.
Market Cap
1.77B
Enterprise Value
1.33B
1-Year Change
122.97%
Global Rank
Country Rank
#1,853 United States
Category
ChartMarket Cap Chart
Since October 11, 2019, Vir Biotechnology's market cap has increased from $1.53B to $1.77B, an increase of 15.51%. That is a compound annual growth rate of 2.08%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 15, 2026 | 1.77B | 111.19% |
| Dec 31, 2025 | 838.92M | -17.01% |
| Dec 31, 2024 | 1.01B | -25.30% |
| Dec 29, 2023 | 1.35B | -59.83% |
| Dec 30, 2022 | 3.37B | -38.52% |
| Dec 31, 2021 | 5.48B | 60.63% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 11, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Mineralys Therapeutics | 1.85B |
| Agios Pharmaceuticals | 1.84B |
| UroGen Pharma | 1.80B |
| Mesoblast | 1.79B |
| Sarepta Therapeutics | 1.78B |
| Xencor | 1.78B |
| Palvella Therapeutics | 1.77B |
| Zymeworks | 1.77B |